Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
$BCLI Q2 '26 Earnings Results & Recap Brainstorm Cell Therapeutics Inc. reported a net loss of $3.855 million for the three months ended June 30, 2026, compared to a net loss of $2.903 million in the prior year.

Price since post

Full Details

Advertisement|Remove ads.